Clinical Trial Update: The COMBAT HBV Feasibility Trial [Phase 4]

View source ↗

Summary

The COMBAT HBV feasibility trial (Phase 4) sponsored by the University of North Carolina has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Hepatitis B, Vertical Transmission of Infectious Disease | Phase 4 | Status: COMPLETED